Delivery Order SPE2DR25D3104-SPE2DR26FE9CD
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,579.20 for Spikevax 2025-26 vaccine (12 years and up) in 0.5ML syringes, with a completion date of November 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,052.80 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5 mL syringes. This competitively awarded, firm fixed-price contract was executed on December 8, 2025, with an ultimate completion date of December 30, 2025. The pharmaceutical product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,195.02 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine (12 years and up) in 0.5 mL syringes. This firm fixed price, non-set-aside delivery order was awarded on November 17, 2025, with an ultimate completion date of December 9, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office and serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $1,683.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine (12 years and up) in 0.5mL syringes. This contract, issued December 8, 2025, with completion targeted for December 30, 2025, represents a non-set-aside competitive award supporting federal medical supply procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,987.50 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine (12 years and up) in 0.5 mL syringes. This competitively awarded, firm fixed-price contract was issued on November 18, 2025, with an ultimate completion date of December 10, 2025. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,052.80 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5mL syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance based in Conshohocken, Pennsylvania and an ultimate completion date of December 26, 2025. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,579.20 to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up) in 0.5mL syringe format, with completion targeted for December 26, 2025. This competitively awarded, non-set-aside delivery order represents a firm fixed-price transaction executed on December 4, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child order...
- The Defense Logistics Agency awarded a delivery order valued at $1,052.80 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine product (12 years and older), 0.5 mL syringes, on December 12, 2025. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of January 6, 2026, and performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX)...
- The Defense Logistics Agency awarded a $1,579.17 firm fixed price delivery order to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and up), 0.5mL syringes, with an ultimate completion date of December 30, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle that runs through December 2026 and serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 vaccine doses (12 years and up) in 0.5 mL syringes, with a ceiling value of $2,736.13. This firm fixed-price delivery order, issued on December 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The work is scheduled for completion by January...
- SPE2DR25D3104Indefinite Delivery Contract
- SPE2DR25D3104-SPE2DR26FE9CDDelivery Order
The Defense Logistics Agency has awarded a delivery order valued at $1,052.80 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (12Y UP) vaccine product in 0.5ML syringe format. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 12, 2026, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply agreement running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has been competitively selected to supply this vaccine product to support federal military and veteran healthcare systems. The company maintains an extensive portfolio of federal medical contracts with the Defense Logistics Agency, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order contributes to the broader strategic initiative whereby the Defense Health Agency and related government healthcare systems leverage AmerisourceBergen's global pharmaceutical support capabilities to meet vaccine distribution requirements for eligible populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/17/25 |